Zimmer Biomet (ZBH) PT Raised to $153 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $98.88 +0.07%
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 15
Rating Summary:
18 Buy, 27 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 15
Join SI Premium – FREE
Truist Securities analyst Richard Newitter raised the price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $137.00) while maintaining a Hold rating.
You May Also Be Interested In
- UCB SA (UCB:BB) (UCBJY) PT Raised to EUR340 at TD Cowen
- Graco Inc. (GGG) PT Lowered to $80 at DA Davidson
- Honeywell International (HON) PT Lowered to $261 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
